EGFR and triple-negative breast carcinoma: Epidermal growth factor receptor (EGFR)-mediated PI3K/AKT, MAPK, and STAT3 signaling pathways are hyperactivated in the CD44+/CD24− BCSC population in MDA-MB-231, a human triple negative breast cancer cell line [96,97].